Georgios D. Tsormpas, M.D.
Background
2019 - 2021 Royal Infirmary of Edinburgh, Specialist Cardiac Surgeon
2016 - 2019 Euromedica Geniki Kliniki Private Hospital
2015 - 2016 Euromedica - KYANOUS STAVROS
2014 - 2015 Leeds General Infirmary, Cardiac Surgeon
2010 - 2014 Euromedica - KYANOUS STAVROS
2010 Master of Valve (Mitral) course, Monaco, Prof. Gilles Dreyfus
2003 - 2009 Euromedica GENIKI KLINIKI Thessaloniki
Other Interests
Off - Pump CABG Surgery
RALTS AVR
Minimally Invasive Cardiac Surgery (MICS)
Transcatheter Valve Therapies
Robotic Cardiac Surgery
Research
2002 – 2003 Aventis Expedition Study, a double blinded, placebo controlled multinational trial to investigate the effect of IV treatment with the Na+/H+ exhange inhibitor CARIPORIDE (HOE642) on all-cause mortality and non-fatal myocardial infarction in patients at risk for myocardial necrosis during and after coronary artery bypass graft (CABG) surgery (HOE642A/3002). Aventis Pharmaceuticals, Inc. [Cardiac Thoracic Surgery Clinic, “Georgios Papanikolaou” Hospital of Thessaloniki, Greece, Center Sub Investigator]
Additional Educational Information
2016 Minimally Invasive Mitral Repair , Munich Cardiothoracic Center, Germany
2010- Master of Valve (Mitral) course, Monaco, Prof. Gilles Dreyfus.
1999-2003 Cardiothoracic Residency, G. Papanikolaou Hosp.
1996-1999 General Surgery Residency, AHEPA Gen. University Hosp.
1986-1992 Medical School, Aristotelian University of Thessaloniki, Greece.
Printer-friendly [4] Practice Areas
- Cardiac
- Minimally Invasive
- Transcatheter
- Coronary disease
- Extracorporeal circulation
- Heart failure
- Mechanical circulatory assistance
- Pericardium
- Valve disease
- Aortic valve disease
- Mitral valve disease
- Tricuspid valve disease
- Thoracic
- Transplant
- Aorta
- Endovascular
- Critical Care